文献速递中毒与环境急症重症综合管理与镇静镇痛

早期集中苯二氮䓬治疗对重度酒精戒断综合征住院时间的影响

Effect of early and focused benzodiazepine therapy on length of stay in severe alcohol withdrawal syndrome.
PubMed 文献 · Clin Toxicol (Phila) · 2019-02-07
一句话结论在重度酒精戒断综合征患者中,24小时内集中使用苯二氮䓬的方案与住院时间和ICU时间缩短相关(14.0天 vs 9.8天;7.4天 vs 4.4天)。

本研究为前后对照队列研究,在学术医疗中心纳入113例重度酒精戒断综合征患者(PRE组75例,POST组38例)。PRE组按RASS给予症状触发、递增剂量的地西泮和苯巴比妥;POST组采用限时方案:24小时负荷期内递增剂量苯二氮䓬和苯巴比妥,72小时减量期后全部停药,并用SHOT量表辅助RASS评估非激越症状。POST组接受集中治疗的比例更高(73.7% vs 51.3%,p=0.03),住院时间(9.8天 vs 14.0天,p=0.03)和ICU时间(4.4天 vs 7.4天,p=0.03)均显著缩短。作者认为早期集中管理重度酒精戒断综合征与ICU和住院时间缩短相关。

要点

  • 重度酒精戒断综合征定义为需要地西泮剂量>30 mg的患者。
  • 集中治疗定义为在识别酒精戒断综合征后最初24小时内使用>50%的总地西泮用量。
  • POST组采用24小时负荷期递增剂量苯二氮䓬和苯巴比妥、72小时减量期后停药的限时方案。
  • POST组接受集中治疗比例更高(73.7% vs 51.3%,p=0.03),住院时间(9.8天 vs 14.0天,p=0.03)和ICU时间(4.4天 vs 7.4天,p=0.03)显著缩短。

适用人群与场景

  • 纳入重度酒精戒断综合征患者;PRE组2015年1月至11月入院,POST组2016年4月至2017年3月入院。
  • 重度酒精戒断综合征定义为需要地西泮剂量>30 mg。

诊断标准与关键阈值

  • 重度酒精戒断综合征:需要地西泮剂量>30 mg。
  • 集中治疗:在识别酒精戒断综合征后最初24小时内使用>50%的总地西泮用量。

处置流程与药物剂量

  • PRE组:按RASS给予症状触发、递增剂量的地西泮和苯巴比妥。
  • POST组:24小时负荷期内给予递增剂量的苯二氮䓬和苯巴比妥,72小时减量期后全部停药;使用SHOT量表辅助RASS评估非激越症状并指导额外地西泮剂量。

研究设计与关键结果

  • 研究类型为前后对照队列研究,共532例患者使用酒精戒断综合征方案,其中113例发生重度酒精戒断综合征(PRE组n=75,POST组n=38)。
  • PRE组与POST组在年龄、性别、酒精戒断综合征病史和疾病严重程度上匹配。
  • POST组接受集中治疗的比例为73.7%,PRE组为51.3%(p=0.03)。
  • POST组住院时间9.8天 vs PRE组14.0天(p=0.03),ICU时间4.4天 vs 7.4天(p=0.03)。

证据类型、等级与局限

  • 证据类型:前后对照队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,重度酒精戒断综合征的早期集中管理与ICU和住院时间缩短相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Objective: Current evidence supports symptom-triggered therapy for alcohol withdrawal syndrome (AWS). Early, escalating therapy with benzodiazepines (BZD) appears to decrease ICU length of stay (LOS); however, the effect on hospital LOS remains unknown. The hypothesis of this study is that focused BZD treatment in the first 24 h will decrease hospital LOS. Design: Pre-post cohort study. Setting: Academic medical center. Patients: This study included patients with severe AWS. The pre-intervention cohort (PRE) was admitted between January and November 2015. The post-intervention cohort (POST) was admitted between April 2016 and March 2017. Severe AWS was defined as patients requiring diazepam doses of >30 mg. Focused treatment was defined as >50% of total diazepam usage within the first 24 h of recognition of AWS. Intervention: In the PRE group, patients received symptom-triggered, escalating doses of diazepam and phenobarbital based on their Richmond Agitation-Sedation Scale (RASS). In the POST group, patients received a revised, time-limited course of therapy: escalating doses of BZD and phenobarbital were given during a 24-h loading phase, and all therapy was discontinued after a 72-h tapering phase. The SHOT scale was used as an adjunct to RASS to assess non-agitation symptoms of AWS and guide additional diazepam doses. Measurements and main results: The primary outcome was hospital LOS; secondary outcomes included ICU LOS, BZD use, and ventilator-free days. Five hundred thirty-two patients were treated using the AWS protocol; 113 experienced severe AWS. The PRE (n = 75) and POST (n = 38) groups were evenly matched in age, sex, history of AWS, and severity of illness. There was a substantial difference in POST patients who received focused treatment (51.3% vs. 73.7%, p = .03). The POST group had a significant decrease in hospital LOS (14.0 vs. 9.8 days, p = .03) and ICU LOS (7.4 vs. 4.4 days, p = .03). Conclusion: Early, focused management of severe AWS was associated with a decrease in ICU and hospital LOS.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Lee JA, Duby JJ, Cocanour CS, et al. Effect of early and focused benzodiazepine therapy on length of stay in severe alcohol withdrawal syndrome. Clin Toxicol (Phila). 2019. PMID: 30729859. doi:10.1080/15563650.2018.1542701

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。